Axiom Investors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-44,047
| Closed | -$3.73M | – | 133 |
|
|
2018
Q4 | $3.73M | Buy |
44,047
+4,049
| +10% | +$343K | 0.13% | 84 |
|
|
2018
Q3 | $6.85M | Buy |
39,998
+5,429
| +16% | +$930K | 0.2% | 71 |
|
|
2018
Q2 | $4.47M | Buy |
34,569
+319
| +0.9% | +$41.2K | 0.13% | 92 |
|
|
2018
Q1 | $3.53M | Buy |
+34,250
| New | +$3.53M | 0.09% | 110 |
|
|
2016
Q4 | – | Sell |
-19,908
| Closed | -$1.27M | – | 158 |
|
|
2016
Q3 | $1.27M | Sell |
19,908
-51,866
| -72% | -$3.3M | 0.04% | 108 |
|
|
2016
Q2 | $5.34M | Buy |
71,774
+652
| +0.9% | +$48.5K | 0.15% | 68 |
|
|
2016
Q1 | $4.75M | Buy |
71,122
+27,995
| +65% | +$1.87M | 0.15% | 66 |
|
|
2015
Q4 | $2.92M | Buy |
+43,127
| New | +$2.92M | 0.09% | 88 |
|
|
2014
Q3 | – | Sell |
-24,366
| Closed | -$947K | – | 168 |
|
|
2014
Q2 | $947K | Sell |
24,366
-35,105
| -59% | -$1.36M | 0.02% | 141 |
|
|
2014
Q1 | $2.5M | Sell |
59,471
-4,431
| -7% | -$186K | 0.06% | 100 |
|
|
2013
Q4 | $2.1M | Buy |
63,902
+7,316
| +13% | +$240K | 0.06% | 105 |
|
|
2013
Q3 | $1.53M | Buy |
+56,586
| New | +$1.53M | 0.05% | 110 |
|